Supplement kills senescent cells and extends life in mice
A food-derived over-the-counter supplement kills senescent cells and can extend life in mice, according to a new Nature Aging study. University of Chicago researchers found late-life vanadyl sulfate treatment raised male median lifespan 7.4% while improving fitness, metabolism, and senescence markers. The results add fuel to longevity and biohacking interest in clearing aging cells safely.
Key Takeaways
- Vanadyl sulfate disrupted protein handling in senescent cells and triggered apoptosis while affecting healthier cells far less.
- Late-life dosing in male mice raised median lifespan from 887 to 952 days, a 7.4% gain after about 90 days of treatment.
- Aged mice also showed better fitness, less fat accumulation, improved glucose tolerance, and lower senescence markers.
- Benefits appeared in disease models of diabetes, liver fibrosis, atherosclerosis, and lung fibrosis; female lifespan was not tested.
What did the study find about this supplement?
As reported by Lifespan.io, vanadyl sulfate (VS) is naturally present in foods such as shellfish, mushrooms, and soybeans and is sold as an over-the-counter supplement. Previous work had linked it to glucose processing.
Jin Cheng’s lab screened a library of nutrients, metabolites, and dietary supplements for senolytic activity that would remain relatively safe for non-senescent cells. In vitro screens produced 68 candidates, with VS among the top hits.
In naturally aged mice, 76-week-old animals received VS in drinking water for 13 weeks, with younger 12-week-old mice as a reference. Most measurements used about 12 to 15 mice per group. Treated animals improved hanging endurance, reduced fat accumulation, and showed better glucose tolerance, plus improved liver and kidney markers and less kidney inflammation.
Those gains lined up with drops in senescence markers SA-β-gal, p16, and p21, along with lower inflammatory gene expression.
How much did lifespan and healthspan improve?
A roughly 90-day course started in male mice at about 71 weeks of age lifted median lifespan from 887 to 952 days, or 7.4%. Lifespan.io notes the result is striking given the late start, short treatment window, and relatively long-lived controls.
The cohort was small, about 20 mice per group, and the lifespan increase barely reached statistical significance. That caveat matters for anyone reading mouse longevity headlines as human advice.
In a follow-up, aged mice took VS for six weeks and then either continued or returned to ordinary water. Circulating vanadium fell back to baseline after withdrawal, yet improvements in fitness, fat accumulation, glucose tolerance, and several tissue measures largely held through follow-up. That pattern fits lasting tissue changes such as senescent-cell clearance, though it does not prove that mechanism on its own.
Aged female mice improved endurance, metabolic measures, and senescence-associated markers after three months. Female lifespan was not tested. VS also improved disease-linked metrics in mouse models of diabetes, liver fibrosis, atherosclerosis, and lung fibrosis.
Why does vanadyl sulfate kill senescent cells?
Working with senescent fibroblasts, the team found VS quickly disrupted protein handling and pushed cells into apoptosis, a death pathway senescent cells usually resist. Signs pointed to protein aggregation and impaired clearance of misfolded proteins.
VS acted as a mild oxidant that promoted disulfide bond formation. Healthy cells largely coped; senescent cells did not. The vulnerability tracked with glutathione metabolism: senescent cells accumulate oxidized glutathione (GSSG) when glutathione reductase is scarce, creating conditions for VS-mediated stress.
Senescent cells also drive chronic inflammation through the senescence-associated secretory phenotype (SASP). Separate Aging Cell work summarized by Lifespan.io argues that inflammaging and poor sleep reinforce each other, underscoring why researchers keep chasing inflammatory aging drivers. This Nature Aging paper itself reports mouse and cell data, not human outcomes.
Bottom line: a common mineral supplement showed clear senolytic activity and late-life lifespan extension in male mice, but the mouse cohorts were modest and human outcomes remain unproven.